When the COVID-19 pandemic stunned the world in 2020, researchers at ORNL wondered how they could extend their support and help
Practical fusion energy is not just a dream at ORNL. Experts in fusion and material science are working together to develop solutions that will make a fusion pilot plant — and ultimately carbon-free, abundant fusion electricity — possible.
To achieve practical energy from fusion, extreme heat from the fusion system “blanket” component must be extracted safely and efficiently. ORNL fusion experts are exploring how tiny 3D-printed obstacles placed inside the narrow pipes of a custom-made cooling system could be a solution for removing heat from the blanket.
It’s a simple premise: To truly improve the health, safety, and security of human beings, you must first understand where those individuals are.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
ORNL manages the Innovation Network for Fusion Energy Program, or INFUSE, with Princeton Plasma Physics Laboratory, to help the private sector find solutions to technical challenges that need to be resolved to make practical fusion energy a reality.
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.